Revolution Medicines, Inc. RVMD Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s total equity?
- Revolution Medicines, Inc. (RVMD) reported total equity of $1.5B in Q1 2026.
- How has Revolution Medicines, Inc.'s total equity changed year-over-year?
- Revolution Medicines, Inc.'s total equity decreased by 27.8% year-over-year, from $2.08B to $1.5B.
- What is the long-term trend for Revolution Medicines, Inc.'s total equity?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s total equity has grown at a 28.0% compound annual growth rate (CAGR), from $474.68M to $1.63B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.